CXCR2 is of particular interest because its primary ligand CXCL8 exerts strong pro-tumor effects through recruitment of myeloid derived suppressor cells (MDSCs) [45], enhancement of angiogenesis [46] and increased tumor metastases [44, 47]. The gene discussed is CXCL8; the disease is neoplasm.